Blog

The 3 W’s of Regulatory Success: What to Do, When to Do It, and Why It Takes Avania

December 23, 2022

Blog

The Right Road to Approval: The Pros and Cons of
3 Regulatory Pathways

December 23, 2022

Blog

Clinical Evaluations From MDD to MDR

May 11, 2022

White Paper

Path to Approval: Why the FDA Q-Submission Program Is a Key Regulatory Strategy Component

White Paper

The Benefits of a Breakthrough: The Advantages of FDA Breakthrough Designation for Patients and Medical Device Manufacturers

White Paper

Beyond the CE Mark: How to Collect Clinical Evidence to Ensure EU MDR Compliance

White Paper

Navigating the Pre-Market EU MDR Journey

Brochure

It Takes Avania Brochure

Blog

EU Medical Device Regulation 2017/745 – First Formal Amendment, Delaying Date of Application

May 4, 2020

Blog

Post-market surveillance under a “522 order” — why, what, and how?

April 9, 2020